Search
  • Within this site
AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.
Back to search results

GLUT4 SELECTIVE INHIBITORS FOR CANCER THERAPY


Technology Benefits

More effective than current MM treatmentsNew mechanism of action targeting glucose uptake in cancer cells


Detailed Technology Description

A novel drug compound that targets GLUT4 expression and glucose uptake in cancer cells. #cancer #therapeutic #chemical #medicinal #drugdiscovery


Country/Region

USA

For more information, please click Here
Business of IP Asia Forum
Desktop View